Nasal antiviral blocks SARS-CoV-2 infection in mice

A compound delivered into the nose blocked a protein used by SARS-CoV-2 to get into cells and prevented severe infection in mice.
Source: NIH Research Matters from the National Institutes of Health (NIH) - Category: Consumer Health News Source Type: news